We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





ADLM 2024 Showcases Breakthrough Innovations Shaping Future of Clinical Testing

By LabMedica International staff writers
Posted on 30 Jul 2024
Print article
Image: The ADLM 2024 Clinical Lab Expo features 900+ exhibitors and 200+ new products/services (Photo courtesy of ADLM)
Image: The ADLM 2024 Clinical Lab Expo features 900+ exhibitors and 200+ new products/services (Photo courtesy of ADLM)

The Association for Diagnostics & Laboratory Medicine (ADLM, Washington, DC, USA) is hosting the ADLM 2024 Clinical Lab Expo (formerly AACC Annual Scientific Meeting & Clinical Lab Expo) in Chicago from July 28 – August 1, 2024, showcasing breakthrough innovations that are shaping the future of clinical testing.

ADLM 2024 Clinical Lab Expo is the premier global laboratory medicine exposition and the place to learn about the breakthrough innovations shaping the future of clinical testing and patient care. Dedicated to achieving better health through laboratory medicine, ADLM brings together more than 70,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science. This year, ADLM’s Clinical Lab Expo is providing attendees with access to nearly 900 exhibitors across 200+ product categories to learn about the latest technologies, services, and solutions for the lab and beyond. Attendees can visit the electronic billboard outside the Expo Hall entrance to learn about innovative new products and services. They will have the opportunity to interact with the showcase to obtain detailed product and service information. Attendees can also find out about new diagnostic breakthroughs and critical lab medicine developments in the Exhibit Hall Theaters, which are conveniently located on the Expo show floor.

Several changes have impacted laboratory medicine that is being reflected in ADLM 2024 in three main ways: greater intersection between laboratory medicine disciplines; integration of automation into the clinical microbiology space; and the increased leveraging and utilization of data analytics, including large language model artificial intelligence (AI) and data visualization. Another topic in focus at the meeting is how the clinical laboratory community can respond to the evolving landscape of laboratory-developed tests, particularly in light of the recent Food and Drug Administration (FDA) final ruling that will go into effect in May 2027.

Additionally, ADLM 2024 is bringing together global leaders for an immersive experience featuring 5 plenaries, nearly 70 scientific sessions, more than 170 roundtables, and a showcase of over 700 posters, offering something for everyone in laboratory medicine. Each day, Sunday – Thursday, the conference begins with a thought-provoking Plenary delivered as a keynote lecture by a world-renowned expert. Plenaries will address timely topics applicable to all laboratorians and span the breadth of research and medicine. Scientific Sessions represent the core of ADLM 2024 with nearly 70 sessions taking place from Monday – Thursday. Scientific Sessions present the latest scientific information on all aspects of laboratory medicine and include a variety of education formats, presentation styles, and audience engagements. Scientific Sessions also include specially developed and invited sessions from ADLM collaborations and divisions.

Roundtables are special ticketed sessions that take place from Monday – Wednesday as 1-hour interactive small group discussions with up to 10 participants. These small groups allow for a unique and highly engaging experience where participants get direct interaction with the presenter and opportunities to both learn and ask questions. Topics range across the spectrum of laboratory medicine and focus on practical skills and case examples. ADLM's Poster Hall provides a wide collection of 700+ poster presentations that take place on Tuesday and Wednesday as an open-access hall in the ADLM Clinical Lab Expo. Topics span the full breadth of laboratory medicine and often represent the latest in cutting-edge research. The ADLM Poster Hall is a unique opportunity to directly connect with poster presenters at their posters during unopposed presenter discussion periods. ADLM 2024 is also home to specially developed sessions and competitions. At a special session of ADLM’s Disruptive Technology Award Competition held in the plenary hall, three diagnostic developers are presenting data on their innovative technologies. A panel of expert judges will be evaluating all presented testing solutions based on feasibility and performance, and the audience will also vote for their favorite technology.

Related Links:
ADLM

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centromere B Assay
Centromere B Test
New
Immunofluorescence Analyzer
MPQuanti

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.